Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11883359
Adapter for use in a planetary mixer
granted -
US 11882920
Systems, devices and methods for styling hair
granted -
US 11885861
3-dimensional representations of post-contrast enhanced brain lesions
granted -
US 11884932
In vitro production of medial ganglionic eminence precursor cells
granted -
US 11884945
Methods for purification of arylsulfatase A
granted -
US 11885807
Method for depleting malignant T-cells
granted -
US 11884746
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted -
US 11884925
Synthetic immunomodulation with a CRISPR super-repressor in vivo
granted -
US 11884920
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
granted -
US 11883535
Liposomal particles, methods of making same and uses thereof
granted -
US 11884930
Method of inactivating a glucocorticoid receptor gene in an isolated cell
granted -
US 11884657
PI-kinase inhibitors with anti-infective activity
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted -
US 11883441
Compositions and methods for inhibiting seizures
granted -
US 11883432
Chimeric antigen receptor system with adaptable receptor specificity
granted -
US 11883223
Hepatic inflammation analysis with dynamic PET
granted -
US 11883386
Prolyl hydroxylase inhibitors and methods of use
granted -
US 11883381
ASH1L inhibitors and methods of treatment therewith
granted -
US 11885806
Method for depleting malignant T-cells
granted -
US 11884736
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
granted -
US 11884731
Vedolizumab for the treatment of fistulizing Crohn's disease
granted -
US 11884707
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
granted -
US 11884647
Compounds and methods for targeting pathogenic blood vessels
granted -
CA 3262048
CX3CR1-BINDING COMPOUNDS, METHODS AND USES THEREOF
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.